Pål Aukrust

Norwegian professor

Born 1950-01-01

Pål Aukrust is …
instance of (P31):
humanQ5

External links are
P2287CRIStin ID18090
P2671Google Knowledge Graph ID/g/11h52mgw3j
P496ORCID iD0000-0002-6509-6221
0000-0003-0919-836X
P214VIAF ID3112148997637459870001

P27country of citizenshipNorwayQ20
P108employerUniversity of OsloQ486156
Oslo University HospitalQ3111191
P734family nameAukrustQ4821657
AukrustQ4821657
AukrustQ4821657
P735given namePålQ15732803
PålQ15732803
P463member ofNorwegian Academy of Science and LettersQ1423356
P106occupationphysicianQ39631
professorQ121594
researcherQ1650915
P5008on focus list of Wikimedia projectWikiProject COVID-19Q87748614
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q406270478-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases
Q449800468-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells
Q40574864A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
Q60388177A Potential Role of the CXC Chemokine GROα in Atherosclerosis and Plaque Destabilization
Q40386708A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue
Q49515324A Young, Immunocompetent Woman with Small Bowel and Hepatic Mucormycosis Successfully Treated with Aggressive Surgical Debridements and Antifungal Therapy
Q34426813A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells
Q39837123A complex role of activin A in non-alcoholic fatty liver disease
Q38660995A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases
Q83586244A helicopter flight does not induce significant changes in systemic biomarker profiles
Q93158379A man in his forties with increasing shortness of breath
Q37427214A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction
Q82725257A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease
Q50959517A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury? Reply.
Q33632677A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice
Q38231108A vital role for complement in heart disease
Q91960551ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial
Q47880025Abnormal interleukin-7 function in common variable immunodeficiency
Q71535844Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections
Q112299064Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction
Q41163325Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice
Q35597343Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms
Q49047720Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke
Q37786647Activated platelets and atherosclerosis
Q42219392Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
Q84962514Activation of Notch signaling in cardiomyocytes during post-infarction remodeling
Q77513220Activation of leukocytes during the uteroplacental passage in preeclampsia
Q39763541Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
Q72222617Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation
Q83207389Activin A and cardiovascular disease in type 2 diabetes mellitus
Q42933454Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis
Q37847440Activin A in nonalcoholic fatty liver disease
Q80152966Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor
Q35797015Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
Q48500144Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
Q38956465Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells
Q44399693Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART.
Q77579832Adhesion molecules in common variable immunodeficiency (CVID)--a decrease in L-selectin-positive T lymphocytes
Q39399393Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly
Q90482183Adipokines and macrophage markers during pregnancy-Possible role for sCD163 in prediction and progression of gestational diabetes mellitus
Q85315049Adipose tissue distribution in relation to insulin sensitivity and inflammation in Pakistani and Norwegian subjects with type 2 diabetes
Q77953405Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system
Q90724383Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes
Q44967475Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure
Q47577999Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia
Q36145827Agents targeting inflammation in heart failure
Q41078217Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure
Q40753393Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation
Q39064202Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia
Q57452552An association between YKL-40 and type 2 diabetes in psychotic disorders
Q35064061An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) mice
Q83454471Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis--a pilot study
Q96160627Anti-inflammatory effects of non-statin low-density lipoprotein cholesterol-lowering drugs: an unused potential?
Q36425459Anti-inflammatory trials in chronic heart failure.
Q82891570Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions
Q46513414Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways
Q35756182Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus
Q41643052Association between altered brain morphology and elevated peripheral endothelial markers--implications for psychotic disorders
Q46585343Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls
Q41086656Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells
Q34676160Association of ficolin-3 with severity and outcome of chronic heart failure
Q43251081Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
Q36001528Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
Q33788258Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis
Q98206078Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders
Q37332292Atherosclerotic plaque stability--what determines the fate of a plaque?
Q52316983Attenuated Notch signaling in schizophrenia and bipolar disorder.
Q59793870Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis
Q50083483Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals
Q42526688Base excision repair activities in organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation
Q81203602Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody
Q46535201Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome
Q58840336Body composition and plasma levels of inflammatory biomarkers in COPD
Q40924208Body mass index influence interferon-beta treatment response in multiple sclerosis
Q42538647Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid Arthritis
Q90285273C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes
Q47191457C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
Q39838882C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
Q91151203CCL21 and prognosis in acute coronary syndrome
Q88452447CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
Q34619812CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials
Q80733397CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice
Q61829028CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS
Q40347984CVID and Celiac Disease
Q40073242CXC chemokine ligand 16 is increased in gestational diabetes mellitus and preeclampsia and associated with lipoproteins in gestational diabetes mellitus at 5 years follow-up
Q73690935CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells
Q73573609CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes
Q44070141CXCL16 in HIV infection - a link between inflammation and viral replication
Q97883180Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
Q38457532Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation
Q39582594Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein
Q43409399Carrier rate of resistant enterococci in a tertiary care hospital in Norway.
Q92601752Caspase-1 induces smooth muscle cell growth in hypoxia-induced pulmonary hypertension
Q80722859Changes in the cytokine network and complement parameters during open heart surgery
Q34674064Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma
Q37231421Chemokines and cardiovascular risk
Q44782672Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation
Q79665134Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
Q74537830Chemokines and leukocyte activation in the fetal circulation during preeclampsia
Q73738653Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection
Q80265488Chemokines in cardiovascular risk prediction
Q46778209Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES.
Q74263491Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets
Q83466863Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle
Q38723655Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses
Q82261730Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10
Q63727982Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis
Q99413492Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
Q39193513Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
Q43965156Churg-Strauss syndrome after treatment with Singulair (montelukast)
Q91242823Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway
Q38979779Circulating annexin A5 predicts mortality in patients with heart failure
Q40580071Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia
Q54551355Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome.
Q57470009Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppression
Q35026334Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin
Q92530848Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T
Q45756867Circulating levels of RANTES in human immunodeficiency virus type 1 infection: effect of potent antiretroviral therapy
Q60774597Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study
Q83370054Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure
Q53268242Circulating nucleosomes in chronic heart failure.
Q80665048Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes
Q54591387Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study.
Q45906534Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction.
Q100300665Commentary: Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy
Q43540341Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis
Q42255402Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.
Q41226485Complement Activation Correlates With Disease Severity and Contributes to Cytokine Responses in Plasmodium falciparum Malaria
Q51302706Complement activation and cytokine and chemokines release during mediastinitis.
Q40520440Complement activation by cholesterol crystals triggers a subsequent cytokine response
Q40684844Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment
Q92755379Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling
Q73740722Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression
Q41992684Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study
Q42552485Correction: Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms
Q38601679Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation
Q43291657Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Q81540101Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure
Q34682109Cytokine network in adults with falciparum Malaria and HIV-1: increased IL-8 and IP-10 levels are associated with disease severity
Q74595368Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
Q35091837Cytokine network in scrub typhus: high levels of interleukin-8 are associated with disease severity and mortality
Q47787677Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP.
Q46651591Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases
Q48240599Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia
Q24799394Cytokines as new treatment targets in chronic heart failure
Q45101318Cytomegalovirus (CMV) pneumonitis in AIDS patients: the result of intensive CMV replication?
Q44650890Cytomegalovirus Infection Induces Production of Human Interleukin-10 in Macrophages
Q44732899Cytomegalovirus disease in the upper gastrointestinal tract. Endoscopic findings
Q36245157Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children
Q54433529De novo 19p13.2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability.
Q46985729Decorin, lumican, and their GAG chain-synthesizing enzymes are regulated in myocardial remodeling and reverse remodeling in the mouse
Q89937225Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells
Q45751621Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy
Q83864020Decreased endomyocardial RANKL expression in transplant coronary artery disease
Q42277348Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress
Q45397427Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy
Q73486387Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses
Q40224562Defective IL-4 signaling in T cells defines severe common variable immunodeficiency
Q89828447Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma
Q58796581Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
Q53289085Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors.
Q40765491Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA.
Q39278842Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
Q57315838Dickkopf-1 Enhances Inflammatory Interaction Between Platelets and Endothelial Cells and Shows Increased Expression in Atherosclerosis
Q33589324Differences in insulin sensitivity, lipid metabolism and inflammation between young adult Pakistani and Norwegian patients with type 2 diabetes: a cross sectional study
Q43489330Different COPD disease characteristics are related to different outcomes in the 6-minute walk test
Q45753594Different effect of 1,25-dihydroxyvitamin D3 on replication of Mycobacterium avium in monocyte-derived macrophages from human immunodeficiency virus-infected subjects and healthy controls
Q58715724Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis
Q60198843Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D
Q96829002Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
Q101121172Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension
Q43613617Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosis
Q44508807Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants
Q63430774Down-regulated expression of PPARα target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFα
Q70489764Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency
Q46247298Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins
Q81730161Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
Q45760209Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients wi
Q64965929Early anti-thrombotic and anti-inflammatory actions of statins and fibrates--time for adjuvant therapy in acute coronary syndromes?
Q92183782Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
Q57822696Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
Q60302334Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy—Results of a Randomized, Multicenter Trial
Q89400922Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
Q54690438Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - potential role of prostaglandin E2.
Q74598927Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure
Q84586692Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes
Q47369556Effect of exercise training in patients with heart failure: a pilot study on autonomic balance assessed by heart rate variability
Q52042595Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity.
Q43601429Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
Q73250285Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
Q39374116Effect of high-intensity interval training on progression of cardiac allograft vasculopathy
Q91066288Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women
Q40241842Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction
Q32083263Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF).
Q48523684Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery
Q43542961Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
Q51738018Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease.
Q44209429Effect of thalidomide in patients with chronic heart failure
Q46814878Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
Q44877647Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
Q78402091Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients
Q92557923Effects of interval training on inflammatory biomarkers in patients with ischemic heart failure
Q45760117Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection
Q34277511Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study
Q91006551Elevated Cholesteryl Ester Transfer Protein Activity Early in Pregnancy Predicts Prediabetes 5 Years Later
Q74428129Elevated circulating levels of C-C chemokines in patients with congestive heart failure
Q40898750Elevated inflammatory markers in preeclamptic pregnancies, but no relation to systemic arterial stiffness
Q46131579Elevated levels of activin A in clinical and experimental pulmonary hypertension
Q44781958Elevated levels of activin A in heart failure: potential role in myocardial remodeling
Q32025738Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events
Q92995476Elevated levels of the secreted wingless agonist R-spondin 3 in preeclamptic pregnancies
Q99720558Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement
Q45772069Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection
Q73834160Elevated plasma levels of reduced homocysteine in common variable immunodeficiency--a marker of enhanced oxidative stress
Q99708092Elevated plasma sTIM-3 levels in severe Covid-19 patients
Q85374055Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis
Q43895869Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events.
Q72668304Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes
Q47394203Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Q44924891Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality
Q33731986Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function
Q43237772Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
Q91151828Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning
Q40663463Endostatin is higher and associated with pulmonary involvement in primary Sjögren's syndrome
Q40327271Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
Q45758382Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection
Q40624371Enhanced base excision repair capacity in carotid atherosclerosis may protect nuclear DNA but not mitochondrial DNA.
Q79106754Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
Q79434482Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
Q74194624Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin
Q72106184Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency
Q45757567Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection
Q43575647Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS).
Q78108701Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
Q44377514Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy
Q33383387Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
Q40368553Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis
Q79292895Enhanced platelet activation in hyperhomocysteinemic individuals
Q73279514Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy
Q46611365Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling
Q35102442Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway
Q30405122Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
Q53158098Exercise training decreases plasma levels of soluble CD40 ligand and P-selectin in patients with chronic heart failure.
Q84666354Explained variance for blood gases in a population with COPD
Q52316128Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder.
Q104483762Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
Q46191844Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy
Q44482796Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects
Q35553707Expression of matrix metalloproteinases in patients with Wegener's granulomatosis
Q40242687Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway
Q45214403Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy
Q34103370Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke
Q83784780Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality
Q51363929Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.
Q43957659Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects
Q44356342Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects
Q84273913Galectin-3 in heart failure: high levels are associated with all-cause mortality
Q34269132Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Q51996960Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells.
Q41470716Genetic variants in the DNA repair gene NEIL3 and the risk of myocardial infarction in a nested case-control study. The HUNT Study
Q45751244Glutathione redox disturbances in human immunodeficiency virus infection: immunologic and therapeutic consequences
Q36913741Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy
Q100518584Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
Q93158329Haemophagocytic lymphohistiocytosis in COVID-19 cases?
Q38030553Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests
Q44697082Herpes simplex virus infection of the central nervous system
Q39903365High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Q61066379High Levels of S100A12 Are Associated With Recent Plaque Symptomatology in Patients With Carotid Atherosclerosis
Q41137641High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
Q34637905High frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders
Q83749896High intensity interval training reduces systemic inflammation in post-PCI patients
Q46702852High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
Q59812665High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
Q40289955High physical fitness is associated with reduction in basal- and exercise-induced inflammation
Q53371250High resolution computed tomography and pulmonary function in common variable immunodeficiency.
Q39765481High serum CXCL10 in Rickettsia conorii infection is endothelial cell mediated subsequent to whole blood activation
Q39567915High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients
Q48540294High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis
Q48288216Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors
Q87422395Highly sensitive troponin T in patients with acute ischemic stroke
Q92504933Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes
Q45382212Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication
Q96821982How does COVID-19 affect the brain?
Q44120998Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes
Q44437789Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
Q79274591Hyperhomocysteinemic Subjects Have Enhanced Expression of Lectin-Like Oxidized LDL Receptor-1 in Mononuclear Cells
Q44228607Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension
Q95939833Høyt serum-ferritin ikke kun uttrykk for leversvikt
Q39901518IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients
Q61829029IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy
Q58746571IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
Q41536733IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
Q41050545IRF4 Is a Critical Gene in Retinoic Acid-Mediated Plasma Cell Formation and Is Deregulated in Common Variable Immunodeficiency-Derived B Cells
Q34498817Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors
Q37700032Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes
Q47118417Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients
Q58123225Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
Q77828328Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
Q44416290Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells
Q73513244Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
Q35097101Immunomodulating therapy: new treatment modality in congestive heart failure
Q44086571Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy
Q54224356Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.
Q38734509Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus
Q91529047Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency
Q45261251Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
Q51890558Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras.
Q83854535Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects
Q44448935Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I.
Q53663812Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate.
Q93161214Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic Stenosis
Q110220761Increased Interleukin-6 and Macrophage Chemoattractant Protein-1 are associated with Respiratory Failure in COVID-19
Q50059271Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack
Q38660961Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
Q36752011Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation
Q41089756Increased Serum Levels of the Notch Ligand DLL1 are Associated with Diastolic Dysfunction, Reduced Exercise Capacity, and Adverse Outcome in Chronic Heart Failure
Q43116827Increased YKL-40 expression in patients with carotid atherosclerosis
Q54085440Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency.
Q84114091Increased circulating mitochondrial DNA after myocardial infarction
Q51425425Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus.
Q77564184Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia--possible role of platelet activation
Q42207429Increased endothelial and macrophage markers are associated with disease severity and mortality in scrub typhus
Q80916754Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
Q38832892Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages
Q46419664Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro
Q80579654Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation
Q44820281Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
Q35089106Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection
Q80442574Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication
Q40174095Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
Q74292256Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure
Q46967951Increased inflammatory markers in children with familial hypercholesterolaemia
Q110220757Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients
Q91420650Increased interleukin 18 activity in adolescents with early-onset psychosis is associated with cortisol and depressive symptoms
Q48714746Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention
Q110220758Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
Q40352345Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects
Q54378142Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
Q73418675Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency
Q34277432Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure
Q28200764Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation
Q42279836Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection
Q40473187Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets.
Q57315827Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis – Potential role in plaque stabilization
Q42208018Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients
Q43240307Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling
Q41627009Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment
Q39528611Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment
Q43807633Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis
Q35088628Increased severity and mortality in adults co-infected with malaria and HIV in Maputo, Mozambique: a prospective cross-sectional study
Q34983608Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis
Q28575465Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Q42220189Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis
Q91799589Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
Q35756990Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin
Q44909225Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
Q81576009Inflammation and depression: further studies are needed
Q37090971Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
Q36314881Inflammation in coronary artery disease: potential role for immunomodulatory therapy
Q34999439Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity
Q36198484Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications
Q47728205Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study
Q64107051Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Q38246972Inflammatory cytokines as biomarkers in heart failure
Q46927699Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.
Q38018808Inflammatory cytokines in heart failure: mediators and markers
Q40774386Inflammatory evidence for the psychosis continuum model
Q78492761Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10
Q54786635Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis.
Q91246305Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors
Q91899010Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors - ERRATUM
Q41247232Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls
Q83192731Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease
Q45960720Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose.
Q81065355Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis
Q84014888Inflammatory response to percutaneous coronary intervention in stable coronary artery disease
Q44896221Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction
Q43083652Inflammatory role of platelets in acute coronary syndromes
Q46507958Inhibition of protein kinase A improves effector function of monocytes from HIV-infected patients
Q32055041Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes
Q73486184Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection
Q28285454Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder
Q46611355Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency
Q97565284Interleukin 18 (IL-18) and its binding protein (IL-18BP) are increased in patients with epilepsy suggesting low-grade systemic inflammation
Q41504728Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis
Q47363732Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation
Q44392834Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study
Q50781571Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms.
Q38974452Interleukin-10 increases reverse cholesterol transport in macrophages through its bidirectional interaction with liver X receptor α.
Q50059664Interleukin-22 reverses human islet dysfunction and apoptosis triggered by hyperglycemia and LIGHT.
Q37153680Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study
Q51672778Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment.
Q89367585Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction
Q38183314Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure
Q28195974Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets
Q91979457Interruption of the CXCL13/CXCR5 Chemokine Axis Enhances Plasma IgM Levels and Attenuates Atherosclerosis Development
Q45903214Intestinal Kaposi sarcoma in a lung transplant recipient: therapy with mammalian target of rapamycin inhibitor and immunosuppression reduction.
Q39714745Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
Q58867594Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction
Q64921564Is apoptosis an important pathogenic factor in cardiovascular disease?
Q35761506Krill oil attenuates left ventricular dilatation after myocardial infarction in rats
Q84445078LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia
Q37242976LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro
Q83883509Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation
Q33886486Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload
Q40231142Large Reduction in Adiponectin During Pregnancy Is Associated With Large-for-Gestational-Age Newborns
Q45079437Left atrial myxoma and systemic AL-amyloidosis
Q92214138Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
Q37576401Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus
Q38904169Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial
Q40251451Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function
Q64943100Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease.
Q64885097Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study.
Q74351635Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation
Q46053350Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
Q38737583Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
Q45097812Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy
Q91523388Lipoprotein(a) concentration is associated with plasma arachidonic acid in subjects with familial hypercholesterolaemia
Q73781836Lipoteichoic acid is a potent inducer of cytokine production in rat and human Kupffer cells in vitro
Q40417705Liver transplantation in patients with primary antibody deficiency
Q112725400Low CETP activity and unique composition of large VLDL and small HDL in women giving birth to small-for-gestational age infants
Q92708686Low Cellular NAD+ Compromises Lipopolysaccharide-Induced Inflammatory Responses via Inhibiting TLR4 Signal Transduction in Human Monocytes
Q40634829Low Circulating Levels of Mitochondrial and High Levels of Nuclear DNA Predict Mortality in Chronic Heart Failure
Q49241621Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia
Q42101882Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).
Q36538797Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study
Q92920677Low fibre intake is associated with gut microbiota alterations in chronic heart failure
Q44914830Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy
Q40778270Low levels of short- and medium-chain acylcarnitines in HIV-infected patients
Q81633506Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
Q79780562Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo
Q101381774Lung CD4+ T cells in patients with lung fibrosis produce pro-fibrotic IL-13 together with IFNγ
Q47749742Lung disease, T-cells and inflammation in common variable immunodeficiency disorders
Q40670646Macrophage migration inhibitory factor, a role in COPD.
Q93062616Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts
Q79255657Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
Q43664563Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy
Q44814395Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset
Q38218468Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
Q85581414Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Q40991292Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
Q37439428Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis
Q35790282Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection
Q35406034Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
Q60198840Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo
Q81542969Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection
Q74414130Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes
Q40172387Monocyte/macrophage and T cell activation markers are not independently associated with MI risk in healthy individuals - results from the HUNT Study
Q87397471Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes
Q48663980Myocardial Function by Two-Dimensional Speckle Tracking Echocardiography and Activin A May Predict Mortality in Patients with Carcinoid Intestinal Disease
Q30611192Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
Q73937454Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease
Q73942551Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
Q100413329N6-methyladenosine in RNA of atherosclerotic plaques: An epitranscriptomic signature of human carotid atherosclerosis
Q40385779NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture
Q36956703NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
Q92404842NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity
Q90480411NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium
Q40169693NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
Q104064422NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet
Q90279953NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction
Q48760535NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome
Q41956073Natural products can be hazardous to health
Q41826070Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice
Q52008827Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users (IVDUs): a follow-up study.
Q52061222Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users.
Q43056315Neutrophil gelatinase-associated lipocalin: a biomarker in COPD.
Q45164914Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages
Q83748739No inflammatory response related to pulmonary hemodynamics in children with systemic to pulmonary shunts
Q96220491Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform
Q41632689Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial
Q90628427OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation
Q84132906Occupational exposure to bacterial single cell protein induces inflammation in lung and blood
Q43729212Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients
Q32023336Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients
Q50059262Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
Q39992061Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003.
Q43246905Osteoprotegerin concentrations and prognosis in acute ischaemic stroke
Q36295418Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
Q24626094Osteoprotegerin levels in patients with severe mental disorders
Q84220523Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
Q38495982Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Q84763540Osteoprotegerin: a biomarker with many faces
Q83070486Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
Q46224491Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia
Q44108169PKAI as a potential target for therapeutic intervention.
Q40451816Palmitate promotes inflammatory responses and cellular senescence in cardiac fibroblasts.
Q40293658Patients with depression display cytokine levels in serum and cerebrospinal fluid similar to patients with diffuse neurological symptoms without a defined diagnosis
Q44604927Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo Dependency of xanthomas/xanthelasms, smoking and gender
Q45986084Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation.
Q40422962Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency
Q48449397Peak oxygen uptake during cardiopulmonary exercise testing determines response to cardiac resynchronization therapy
Q56942249Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis
Q48458509Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
Q90268374Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial
Q44752818Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat.
Q43263010Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery
Q30873807Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines
Q60198844Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences
Q38620965Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study
Q74225980Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy
Q83417982Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy
Q33522307Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors
Q40454558Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients.
Q61918731Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels
Q88909991Plasma hepcidin is associated with future risk of venous thromboembolism
Q61066385Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity
Q97518157Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism
Q92819435Plasma levels of interleukin 27 in falciparum malaria is increased independently of co-infection with HIV: potential immune-regulatory role during malaria
Q92905413Plasma levels of mannose-binding lectin and future risk of venous thromboembolism
Q39651215Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients
Q46833415Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients
Q51754844Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function.
Q89795919Plasma parasitemia as assessed by quantitative PCR in relation to clinical disease severity in African adults with falciparum malaria with and without HIV co-infection
Q92471934Plasma tumour necrosis factor correlates with mRNA expression of tumour necrosis factor and mitochondrial transcription factors in skeletal muscle in patients with chronic heart failure treated with cardiac resynchronization therapy: potential role
Q35613674Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity
Q47964957Platelet activation in heart transplant recipients
Q79966465Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes
Q83874889Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
Q45752941Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion
Q73200629Possible role of proinflammatory cytokines in heart allograft coronary artery disease
Q44984913Potential anti-inflammatory role of activin A in acute coronary syndromes
Q36822365Potential mechanisms of benefit with thalidomide in chronic heart failure
Q36283698Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation
Q81585812Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality
Q58761854Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14-16 Weeks' Gestation
Q48445961Predictive value of endostatin in chronic heart failure patients with poor kidney function
Q34287563Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study
Q60952957Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis
Q91143699Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
Q90831363Profiling of immune-related gene expression in children with familial hypercholesterolaemia
Q92037295Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
Q38440524Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial
Q41993082Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.
Q73614958Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure
Q50955029Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure.
Q54093961Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy.
Q30587543Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.
Q45149635Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
Q47870765Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients.
Q43425915Psychological difficulties related to human immunodeficiency virus-1 infection in intravenous drug users
Q81504025Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation
Q39742477Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation
Q79347499Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy
Q43459401Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients
Q43913455Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome
Q44283435Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
Q68223814Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features
Q91047010Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Q91046189Reduced brain-derived neurotrophic factor is associated with childhood trauma experiences and number of depressive episodes in severe mental disorders
Q98564782Reduced levels of circulating adhesion molecules in adolescents with early-onset psychosis
Q71888432Reduced serum level of transforming growth factor-beta in patients with IgA deficiency
Q40945471Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system
Q55034198Relation between food provocation and systemic immune activation in patients with food intolerance.
Q51767101Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).
Q40401947Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever
Q60198849Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo
Q103829228Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results
Q54135975Response to letter from Toldo et al. on "NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective".
Q85638420Retinoic acid improves defective TLR9/RP105-induced immune responses in common variable immunodeficiency-derived B cells
Q36144849Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches
Q40721694Rhabdomyolysis and capillary leak syndrome in a patient treated with topical imiquimod
Q39741712Rickettsia conorii is a potent complement activator in vivo and combined inhibition of complement and CD14 is required for attenuation of the cytokine response ex vivo
Q60907689Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
Q35915851Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study
Q92291144Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study
Q36806972Role of inflammation in the progression of heart failure
Q40361562Role of interleukin-10 in atherogenesis and plaque stabilization
Q90664623Rosuvastatin alters the genetic composition of the human gut microbiome
Q55027396Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas.
Q35750462Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Q87204316Secreted Frizzled-Related Protein 3 (sFRP3) in acute coronary syndromes
Q42255903Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients
Q36519744Secreted Wnt modulators in symptomatic aortic stenosis
Q91305614Selective IgA deficiency in humans is associated with reduced gut microbial diversity
Q91673125Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects
Q91287941Serum Omega-6 Fatty Acids and Immunology-Related Gene Expression in Peripheral Blood Mononuclear Cells: A Cross-Sectional Analysis in Healthy Children
Q58724610Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
Q41335176Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders
Q46090548Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma
Q92838091Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers
Q83244387Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
Q45783344Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters
Q89367588Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction
Q52603943Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome.
Q59275996Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris
Q46798854Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus
Q45752853Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis
Q33791924Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
Q28261811Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
Q42249543Single-nucleotide polymorphisms in Toll-like receptor (TLR)-2, TLR4 and heat shock protein 70 genes and susceptibility to scrub typhus
Q61066384Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability
Q47355225Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?
Q45269812Soluble CD40 ligand in acute and chronic heart failure
Q45012612Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells
Q82356384Soluble CXCL16 and long-term outcome in acute ischemic stroke
Q40878000Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway
Q48568857Soluble CXCL16 predicts long-term mortality in acute coronary syndromes
Q88937328Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
Q91937369Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals
Q48677667Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
Q41624837Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure
Q89704557Soluble T-Cell Immunoglobulin Mucin Domain-3 Is Associated With Hepatitis C Virus Coinfection and Low-Grade Inflammation During Chronic Human Immunodeficiency Virus Infection
Q38459873Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Q60044050Soluble markers of neutrophil, T-cell and monocyte activation are associated with disease severity and parasitemia in falciparum malaria
Q81205152Soluble toll-like receptor 2 in HIV infection: association with disease progression
Q40790855Specific allergen immunotherapy: effect on IgE, IgG4 and chemokines in patients with allergic rhinitis
Q28729147Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies
Q43677519Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences
Q74397732Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects
Q42228228Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment
Q104568536Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers
Q37297571Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype
Q45783304Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival
Q34025504Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis
Q35804806Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
Q43782729Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig
Q47709685Systemic and Airway Inflammation After Exposure to Fumes from Military Small Arms
Q34316549Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis
Q99564634Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Q36526913Systemic inflammation in heart failure--the whys and wherefores
Q83161496Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
Q84323166Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Q40561220Systemic inflammatory responses in African tick-bite fever
Q84738653Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease
Q43058570Systemic markers of inflammation are associated with cardiac allograft vasculopathy and an increased intimal inflammatory component
Q79165580Systemic markers of inflammation--are they useful predictive tools in coronary artery disease?
Q90548908T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF
Q81403706T cells in coronary artery disease: different effects of different T-cell subsets
Q94319011T8. ATHEROGENIC LIPID RATIOS RELATED TO MYELOPEROXIDASE AND C-REACTIVE PROTEIN LEVELS IN PSYCHOTIC DISORDERS
Q41991646TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency
Q37997644TNF revisited: osteoprotegerin and TNF-related molecules in heart failure
Q90420993Tendering for HIV drugs is not clinically justified
Q43284720Testosterone: a novel therapeutic approach in chronic heart failure?
Q63430768Tetradecylselenoacetic Acid, a PPAR Ligand With Antioxidant, Antiinflammatory, and Hypolipidemic Properties
Q46955401Tetradecylthioacetic acid increases fat metabolism and improves cardiac function in experimental heart failure
Q82889166Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats
Q40794866The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis
Q41418523The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial
Q51072106The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Q40225462The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy
Q86088040The Notch ligand Delta-like 1 is elevated and associated with mortality in patients with symptomatic aortic stenosis
Q40333926The alternative complement pathway is dysregulated in patients with chronic heart failure
Q51678036The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.
Q46677502The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
Q56974209The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure
Q91851603The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection
Q39937519The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction
Q39240586The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions
Q28083548The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis
Q37167783The complex role of T-cell-based immunity in atherosclerosis
Q35084669The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets.
Q60198847The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency
Q31152172The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial
Q45000399The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types
Q40787355The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
Q34200352The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure
Q34513415The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling
Q45738367The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy
Q34104103The peripheral blood mononuclear cell microRNA signature of coronary artery disease
Q48274713The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Q43287747The prognostic importance of modifiable risk factors after heart transplantation
Q53082418The relationship between markers of extracellular cardiac matrix turnover: infarct healing and left ventricular remodelling following primary PCI in patients with first-time STEMI.
Q36558817The role of intravenous immunoglobulin in the treatment of chronic heart failure
Q37000806The role of statins in heart failure
Q73297379The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients
Q40361542The tumor necrosis factor superfamily in heart failure
Q50312267The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis
Q110220756The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
Q35768272Therapeutic potential of anticytokine therapy in congestive heart failure
Q34731377Thioredoxin interacting protein is a potential regulator of glucose and energy homeostasis in endogenous Cushing's syndrome
Q33604761Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
Q34050642Toll-like receptor 9 mediated responses in cardiac fibroblasts
Q28541982Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension
Q57750433Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients
Q37799379Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature
Q91025919Treatment of sleep apnea in patients with paroxysmal atrial fibrillation: design and rationale of a randomized controlled trial
Q43238382Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
Q44827257Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy
Q58123267Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy
Q46467659Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
Q45752470Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure
Q37805514Tumor necrosis factor superfamily molecules in acute coronary syndromes
Q42922255Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis
Q51492970Undiagnosed dysglycaemia and inflammation in cardiovascular disease.
Q47561608Up-regulation of NOTCH4 gene expression in bipolar disorder
Q43753126Up-regulation of myocardial DNA base excision repair activities in experimental heart failure
Q92229629Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy
Q63352311Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition
Q73072392Virological and immunological effects of antioxidant treatment in patients with HIV infection
Q60302301Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus-Results of a Multicenter Trial
Q84585887Visfatin/NAMPT - a hot spot in thrombosis?
Q37998508Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology
Q31111834Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort
Q41430215Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
Q40969344Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis
Q35213372Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD
Q33799421Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy
Q40272717Wnt5a is elevated in heart failure and affects cardiac fibroblast function
Q99607093YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis
Q68274442[Cytomegalovirus disease in the gastrointestinal tract]
Q69711893[HIV and the central nervous system]
Q74317378[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]
Q79816446[Should patients with severe sepsis be treated with activated protein C?]
Q68274437[Symptomatic cytomegalovirus infection in patients with acquired immunodeficiency syndrome]
Q69950462[Viral or bacterial meningitis. Differential diagnostic problems]

The articles in Wikimedia projects and languages

nbPål Aukrustwikipedia

Search more.